4CMenB Vaccine Well Tolerated, Immunogenic in US Infants
Summary
A randomized trial finds that the 4CMenB vaccine is well tolerated and produces immune responses in healthy infants when given concomitantly with pneumococcal and other routine infant vaccines.
Description from Medscape.
Who is covering this
-
4CMenB Vaccine Well Tolerated, Immunogenic in US Infants
A randomized trial finds that the 4CMenB vaccine is well tolerated and produces immune responses in healthy infants when given concomitantly with pneumococcal and other routine infant vaccines.
Comments
Comments need JavaScript.